Sister Study To Examine Risk Factors For Breast Cancer In 50,000 Women
Some Children With Hodgkin’s Disease Can Reduce Or Skip Radiation, Study Finds
Breast Implants Don’t Cause Tissue Disorders, NCI Finds
Unscreened Women At High Risk of Breast Cancer
Efaproxyn Improved Survival Of Patients With Brain Mets
Brachytherapy Better Than Surgery For Prostate Cancer
Ohio Center Helps Women Stop Smoking, Reduce Cervical Cancer Risk
Smoking Cessation Training Follows Doctors Into Practice
Degarelix Active In Phase II Trial In Prostate Cancer
Study Opens For Women At Risk of Ovarian Cancer
Centers Recruting Patients With Mantle Cell Lymphoma
NCI-Approved Clinical Trials
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
